Epoetin Theta with a New Dosing Schedule in Anaemic Cancer Patients Receiving Nonplatinum-Based Chemotherapy: A Randomised Controlled Trial

INTRODUCTION: Recombinant human erythropoietin (r-HuEPO) is used to treat symptomatic anaemia due to chemotherapy. A new r-HuEPO, Epoetin theta (Eporatio®), was investigated and compared to placebo in a randomised, double-blind clinical trial in adult cancer patients receiving nonplatinum-based chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Tjulandin, Sergei A, Bias, Peter, Elsässer, Reiner, Gertz, Beate, Kohler, Erich, Buchner, Anton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Inc 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193379/
https://www.ncbi.nlm.nih.gov/pubmed/22022341
http://dx.doi.org/10.1111/j.1753-5174.2011.00035.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193379/
https://www.ncbi.nlm.nih.gov/pubmed/22022341
http://dx.doi.org/10.1111/j.1753-5174.2011.00035.x

Ejemplares similares